Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yamina Rajput

Impact of Omalizumab on Patient Reported Outcomes in Chronic Idiopathic Urticaria: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-Controlled Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Related publications

Impact of Omalizumab Treatment Withdrawal After 24 and 48 Weeks in Patients With Chronic Idiopathic Urticaria: Results From the XTEND-CIU Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab Response in Patients With Chronic Idiopathic Urticaria: Insights From the XTEND-CIU Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Long-Term Outcomes of Omalizumab in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab vs. Placebo in the Management of Chronic Idiopathic Urticaria: A Systematic Review

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Omalizumab Treatment Patterns in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Double-Blind Placebo-Controlled Trial of the Effect of Omalizumab on Basophils in Chronic Urticaria Patients

Clinical and Experimental Allergy
AllergyImmunology
2017English

Re-Evaluation of Need and Tapering of Omalizumab in Chronic Idiopathic Urticaria

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy